| 11. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1117,
1997,
Page 12-12
&NA;,
Preview
|
PDF (1144KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 12. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1117,
1997,
Page 13-13
&NA;,
Preview
|
PDF (1033KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 13. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1117,
1997,
Page 14-14
&NA;,
Preview
|
PDF (1153KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 14. |
Relieving migraine |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1117,
1997,
Page 15-15
&NA;,
Preview
|
PDF (1045KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 15. |
Fortification of food with folic acid: effective dose |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1117,
1997,
Page 16-16
&NA;,
Preview
|
PDF (1126KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 16. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1117,
1997,
Page 17-17
&NA;,
Preview
|
PDF (1021KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 17. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1117,
1997,
Page 18-19
&NA;,
Preview
|
PDF (2225KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 18. |
Troglitazone withdrawn in the UK |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1117,
1997,
Page 19-19
&NA;,
Preview
|
PDF (1030KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 19. |
Can another thalidomide disaster be prevented? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1117,
1997,
Page 20-21
Rosie Stather,
Preview
|
PDF (2227KB)
|
|
摘要:
Thalidomide is experiencing a renaissance despite the fact that the drug is a teratogen and causes polyneuropathy that is frequently irreversible. In the US, the FDA has issued an approvable letter for thalidomide for the treatment of erythema nodosum leprosum, a complication of leprosy,*and in the UK, where it is unlicensed, it has been used for AIDS-related cachexia and aphthous ulcers, and for graft-versus-host disease and inflammatory dermatoses. No other drug has had such a tremendous impact on regulatory and drug safety requirements. Current systems to assess and monitor drug safety were established as a direct result of the 1960s thalidomide tragedy and those charged with assessing and monitoring the safety of drugs still rely on these systems in order to stop a similar disaster from occurring. What went wrong and how such a situation could be prevented from recurring were discussed at the Fifth Annual Meeting of the European Society for Pharmacovigilance [Berlin, Germany; September 1997].
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 20. |
Intensified IDDM therapy increases severe hypoglycaemia risk |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1117,
1997,
Page 21-21
&NA;,
Preview
|
PDF (1046KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
首页
